( January 29, 2026, 12:59 PM EST) -- NEWARK, N.J. — A New Jersey federal judge granted final approval of a $7.5 million class action settlement to end claims that a drug manufacturer knew that its premature birth prevention drug was ineffective and awarded attorney fees, costs and service fee awards for the named plaintiffs....